Actively Recruiting
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
Led by Sun Jing · Updated on 2025-08-08
22
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the efficacy and safety of Nocardia rubra cell wall skeleton in combination with prior second- or third-line regimens for the treatment of potentially hazardous colorectal cancer SD(Stable Disease) status in the real world.
CONDITIONS
Official Title
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older, any gender
- Diagnosed colorectal adenocarcinoma confirmed by pathology or cytology and imaging
- At least one measurable lesion with longest diameter of 10 mm or more by spiral CT or 20 mm or more by conventional CT according to RECIST 1.1 criteria
- Received prior second- or third-line therapy for advanced or metastatic colorectal cancer and have potentially hazardous stable disease status defined by specific tumor size and blood marker changes
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Expected survival of 3 months or longer
- Blood, liver, and kidney function tests within 7 days before screening meet specified thresholds for neutrophils, hemoglobin, platelets, bilirubin, gammaglutaminase, alkaline phosphatase, and creatinine
- Signed informed consent form
You will not qualify if you...
- Known allergic constitution
- Having diabetes
- Active severe infection
- Other conditions considered exclusionary by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029
Actively Recruiting
Research Team
J
Jing Sun
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here